Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

BLRX $1.48 0.1500 +11.28%
DRNA $14.47 1.1100 +8.31%
TGTX $14.18 1.0000 +7.59%
MNKD $2.13 0.1300 +6.50%
NWBO $4.90 0.2800 +6.06%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

KITE $76.05 -6.3200 -7.67%
OMED $21.18 -1.6700 -7.31%
ARGS $3.79 -0.2800 -6.88%
RDUS $56.80 -4.0100 -6.59%
LOXO $30.91 -2.0200 -6.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

New Model Helps Predict Breast Cancer Risk in Hispanic Women

(AACR) Nov 13, 2015 - The first breast cancer risk-prediction model based entirely on data from Hispanic women, including whether a woman was born in or outside of the United States, provided a more accurate assessment of Hispanic women’s risk of developing breast cancer compared with existing models based on data from non-Hispanic women, according to a study presented at the Eighth American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 13-16.
read press release 

Healthy Diet May Reduce Risk of Ovarian Cancer in African-American Women

(AACR) Nov 13, 2015 - A healthy diet may reduce the risk of ovarian cancer in African-American women, according to data presented at the Eighth American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 13-16.
read press release 

Choice in Colon Cancer Screening Linked to More Regular Testing

(Reuters) Nov 12, 2015 - People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests.
read article 

How Pharma Keeps A Trove Of Drug Trials Out Of Public View

(Washington Post/Wonkblog) Nov 12, 2015 - A third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported, according to a new study that grades companies on their transparency.
read article (free registration required) 

Personalized Anti-Nausea Therapy Better for Cancer Patients, Ottawa Researchers

(Ottawa Hospital) Nov 12, 2015 - A new research study led by Dr. Mark Clemons, oncologist and associate cancer research scientist at The Ottawa Hospital, has shown that a personalized approach to treating one of the most expected side-effects of chemotherapy is far more effective than the existing “one size fits all” set of guidelines.
read press release 

Roche Plans to Exit Four Sites, Cut Jobs at Cost of $1.6 Billion

(Bloomberg) Nov 12, 2015 - Roche Holding AG plans to exit four manufacturing sites and pare some jobs in a restructuring program that will cost about 1.6 billion francs ($1.6 billion) over the next five years.
read article 

Women Panic Less When Abnormal Breast Cells Are Not Called Cancer

(Fox Health/Reuters) Nov 12, 2015 - Women may be less likely to panic or pursue aggressive treatment for a common, non-invasive breast tumor if doctors don't use the word "cancer" to describe the abnormal cells, an Australian study suggests.
read article 

Obesity Is Still a Growing Problem for American Adults, CDC Says

(Los Angeles Times/Science Now blog) Nov 11, 2015 - America’s obesity problem just keeps getting bigger.
read article (free registration required) 

Valeant's Favorite Pharmacy Made Life Easy for Doctors, at a Price

(Bloomberg) Nov 12, 2015 - Bill Rietkerk, a New York dermatologist, thought it was a win-win situation.
read article 

Pacific Trade Deal Could Limit Affordable Drugs: World Health Chief

(Reuters) Nov 12, 2015 - A massive trade pact between 12 Pacific rim countries could limit the availability of affordable medicines, the head of the World Health Organization said on Thursday, joining a heated debate on the impact of the deal.
read article 

Novartis, Roche Find 'Outcome-Based' Drug Pricing an Elusive Dream

(Reuters) Nov 12, 2015 - News that Novartis's heart drug Entresto cuts the risk of re-hospitalization might have helped Chief Executive Joe Jimenez realize his ambition of getting insurers to pay more for treatments when they cut overall medical costs.
read article 

Texas Center for Proton Therapy Treats First Patients

(Texas Center for Proton Therapy) Nov 10, 2015 - Texas Center for Proton Therapy has delivered proton beam radiation treatment to its first patients, ushering in a new era of technologically advanced treatment to create more cancer survivors in North Texas.
read press release 

Capital BlueCross Establishes Oncology Program To Improve Care For Cancer Patients

(TheStreet) Nov 11, 2015 - When patients are diagnosed with cancer, they and their family members are immediately faced with a search for answers and the best care possible.
read article 

Testimony at Sheldon Silver’s Trial Suggests How Lucrative Mesothelioma Was

(New York Times) Nov 10, 2015 - The testimony in court on Tuesday had provided an unsparing look at the Darwinian battles among lawyers to sign up clients from a small, lucrative pool of cancer patients who had mesothelioma, a disease that could be traced beyond doubt to asbestos exposure.
read article 

Birmingham Biotech Launches Product to Speed up Cancer Treatment

(Birmingham Business Journal) Nov 11, 2015 - Birmingham's newest biotech company, Circulogene Theranositcs, has commercially launched its proprietary technology that expedites cancer diagnosis and allows for the targeted treatment of up to 10 different types of cancer.
read article 

Toronto Biotech Firm Teams up with Moffitt for Potential Cancer Fighters

(Tampa Bay Business Journal/Morning Edition) Nov 12, 2015 - An agreement between Moffitt Cancer Center and Aptose Biosciences is expected to help Aptose expand its pipeline for cancer-fighting therapies.
read article 

ImmunoCellular Therapeutics Enters into Sponsored Research Agreement with University of Texas MD Anderson Cancer Center to Advance Stem-to-T-Cell Program

(Yahoo! Finance) Nov 12, 2015 - ImmunoCellular Therapeutics, Ltd. today announced it has entered into a sponsored research agreement with Dr. Cassian Yee at the University of Texas MD Anderson Cancer Center.
read article 

Transgene and SillaJen Announce Revised Agreement for Pexa-Vec Oncolytic Viral Therapy and Provide Update on Clinical Development

(Transgene) Nov 12, 2015 - Transgene SA and SillaJen, Inc. today announced that they have signed an amended agreement for the development and commercialization of oncolytic viral therapy Pexa-Vec to streamline the conduct of clinical trials and to reflect important areas of interest for each company.
read corporate press release 

European Scientists Say Weedkiller Glyphosate Unlikely to Cause Cancer

(Reuters) Nov 12, 2015 - Glyphosate is unlikely to cause cancer in humans, according to the European Food Safety Authority (EFSA), which nevertheless proposed new limits on Thursday on the amount of residue of the weedkiller deemed safe for humans to consume.
read article 

New Combination Trial With Lirilumab In Hemato-Oncology

(Innate Pharma) Nov 12, 2015 - Innate Pharma SA announced that a new trial performed by the MD Anderson cancer center started, testing a combination of nivolumab, lirilumab and 5-azacytidine for the treatment of patients with Myelodysplastic Syndrome (MDS).
read corporate press release 

Bristol-Myers Squibb to Present New Data for Opdivo (nivolumab) in Advanced Melanoma, as Monotherapy and in Combination with Yervoy (ipilimumab), at the Society for Melanoma Research 2015 International Congress

(MarketWatch) Nov 12, 2015 - Bristol-Myers Squibb Company today announced results of new clinical research of its Immuno-Oncology agents – Opdivo and Yervoy – will be presented at the Society for Melanoma Research (SMR) 2015 International Congress in San Francisco, CA from November 18 – 21.
read article 

Researchers Call for Hospitals to Establish Bereavement Programs for Families of Deceased Patients

(Dana-Farber) Nov 11, 2015 - Backed by a growing body of research, investigators at Dana-Farber Cancer Institute are calling for all hospitals to establish bereavement programs for families of deceased patients.
read press release 

Change in a Single DNA Base Drives a Childhood Cancer

(CHOP) Nov 11, 2015 - Pediatric oncology researchers have pinpointed a crucial change in a single DNA base that both predisposes children to an aggressive form of the childhood cancer neuroblastoma and makes the disease progress once tumors form.
read press release 

Researchers Develop Molecular Target for Brain Cancer

(Stanford Medicine/Scope blog) Nov 11, 2015 - About 23,000 new cases of brain and central nervous system tumors are diagnosed annually, and more than 15,000 patients are expected to die of brain cancer this year in the United States, according to the American Cancer Society.
read article 

Study Reveals Why Chemotherapy May Be Compromised in Patients with Pancreatic Cancer

(MD Anderson) Nov 11, 2015 - A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy drugs such as gemcitabine are not effective for many pancreatic cancer patients, and perhaps point to new approaches to treatment including enhancing gemcitabine’s ability to stop tumor growth.
read press release